113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 622 / 薬物数 : 485 - (DrugBank : 99) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 168

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03777319 (ClinicalTrials.gov)	December 5, 2018	10/12/2018	Spironolactone Versus Prednisolone in DMD	A Randomized Open Label Trial of SpironolactoneVersus Prednisolone in Corticosteroid-naïve Boys With ...	Muscular Dystrophy, Duchenne	Drug: Spironolactone;Drug: Prednisolone	Kevin Flanigan	Muscular Dystrophy Association	Terminated	4 Years	7 Years	Male	2	Phase 1	United States
2	NCT02354352 (ClinicalTrials.gov)	March 20, 2015	27/1/2015	Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy	Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy	Duchenne Muscular Dystrophy	Drug: Eplerenone;Drug: Spironolactone	Ohio State University	University of California, Los Angeles;University of Utah;University of Colorado, Denver;University o ...	Completed	7 Years	N/A	Male	52	Phase 3	United States

First Previous1Next Last